Autres langues Getein Biotech, Inc

Actions

603387

CNE100002RR9

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 30/04/2024			Varia. 5j.	Varia. 1 janv.
9,39 ^CNY	+1,84 %		+8,55 %	-14,64 %

29/04	Getein Biotech, Inc. présente ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	Getein Biotech, Inc. présente ses résultats pour les neuf mois se terminant le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Getein Biotech, Inc Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Getein Biotech, Inc Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Meihua International Unit, Getein Biotech to Develop COVID-19 Antigen Test Kits, Other In Vitro Diagnostic Products	11/01/23
Meihua International Medical Technologies Co., Ltd. Enters into Strategic Partnership with Getein Biotech Inc. to Jointly Produce and Sell Covid-19 Antigen Test Kits and IVDs	11/01/23
Getein Biotech Gets Regulatory Approval for COVID-19 Kit; Shares Up 9%	12/12/22
Getein Biotech, Inc Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22
Yestar Healthcare, Getein Biotech End Investment Talks	24/08/22
Getein Biotech, Inc Reports Earnings Results for the Half Year Ended June 30, 2022	23/08/22
Yestar Healthcare Holdings Company Limited cancelled the transaction announced on April 8, 2022	23/08/22
Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22
Yestar Healthcare Holdings Company Limited announced that it expects to receive funding from Getein Biotech, Inc	08/04/22
Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2021	11/03/22
Sichuan Getein Biotechnology Co., Ltd. announced that it expects to receive CNY 30 million in funding from Getein Biotech, Inc	24/02/22
Getein Biotech, Inc Reports Earnings Results for the Nine Months Ended September 30, 2021	27/10/21
Getein Biotech, Inc Reports Earnings Results for the Half Year Ended June 30, 2021	17/08/21
Tranche Update on Getein Biotech, Inc's Equity Buyback Plan announced on December 31, 2020.	30/06/21
Getein Biotech, Inc's Equity Buyback announced on December 30, 2020, has expired with 1,560,790 shares, representing 0.43% for CNY 50 million.	29/06/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Getein Biotech, Inc

Actions

603387

CNE100002RR9

Autres langues

Filtres